Lawrence M. Blatt, Ph.D. 13D and 13G filings for Aligos Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-03-12 8:30 pm Purchase | 2025-03-10 | 13D | Aligos Therapeutics, Inc. ALGS | Lawrence M. Blatt, Ph.D. | 175,509 3.200% | 175,509 (New Position) | Filing |